Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis

Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis

Objective: Soluble Tumor Necrosis Factor Receptor II (sTNFR2) is used as a biomarker to study cardiovascular disease (CVD) in diverse populations. TNF inhibitors (TNFi's) are a common treatment for inflammatory conditions. The objective of this study was to examine whether TNFi use impacts meas...

Full description

Bibliographic Details
Main Authors: Nicole Yang, Jie Huang, Michelle Frits, Christine Iannaccone, Michael E. Weinblatt, Nader Rifai, Nancy Shadick, Gary Bradwin, Katherine P. Liao
Format: Article
Language:English
Published: Elsevier 2019-08-01
Series:Practical Laboratory Medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352551718300295

Internet

http://www.sciencedirect.com/science/article/pii/S2352551718300295

Similar Items